A carregar...
Patient considerations in the management of ulcerative colitis – role of vedolizumab
Ulcerative colitis (UC) is a subtype of inflammatory bowel disease which causes inflammation of the large intestine and affects approximately 7.6–24.6 per 100,000 persons. The therapeutic goal for UC patients is inducing remission, maintaining remission, and ideally, obtaining mucosal healing. Vedol...
Na minha lista:
| Publicado no: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548764/ https://ncbi.nlm.nih.gov/pubmed/26316768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S65650 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|